In other words, the margin of dumping in a NME case where Commerce constructs these normal value benchmarks also capture the benefit of any subsidies accruing to the exporter.
Inthe past decade, the number of new drugs or New Molecular Entities (NME), as they are called inthe trade released inthe United States for the treatment of rare diseases has increased dramatically.